Are the long-term adverse events from #ocriplasmin exceeding the risks associated with a vitrectomy? Especially if all four studies were sponsored by the manufacturers of ocriplasmin and up to 20% of patients need further treatment. There's a 90+% success
RT @joaquinfdezoft: Admiration for the determined Commitment of @RCOphth (Royal College Ophthalmologist) to #EvidenceBasedMedicine with its…
RT @CochraneEyes: #Cochrane Corner in Eye: #Ocriplasmin—why isn’t it being used more? https://t.co/pIaQ8v7syP @SunderlandEye @RCOphth @Moor…
RT @joaquinfdezoft: Admiración por la decidida apuesta del @RCOphth (Royal College Ophthalmologist) por la #MedicinaBasadaEvidencia con su…
RT @joaquinfdezoft: Admiración por la decidida apuesta del @RCOphth (Royal College Ophthalmologist) por la #MedicinaBasadaEvidencia con su…
Admiración por la decidida apuesta del @RCOphth (Royal College Ophthalmologist) por la #MedicinaBasadaEvidencia con su Colaboración con @CochraneEyes Editorial en @Eye_Journal: "#Ocriplasmina: ¿Por qué no se está usando más?" Acceso abierto: https://t.c
Admiration for the determined Commitment of @RCOphth (Royal College Ophthalmologist) to #EvidenceBasedMedicine with its Collaboration with @CochraneEyes Editorial in @Eye_Journal: "#Ocriplasmin: Why isn't it being used more?" Open access: https://t.co/
RT @CochraneEyes: #Cochrane Corner in Eye: #Ocriplasmin—why isn’t it being used more? https://t.co/pIaQ8v7syP @SunderlandEye @RCOphth @Moor…
#Cochrane Corner in Eye: #Ocriplasmin—why isn’t it being used more? https://t.co/pIaQ8v7syP @SunderlandEye @RCOphth @Moorfields @CochraneEyes Review: https://t.co/SjvCsCFebR https://t.co/PitDWzvhwJ
Ocriplasmin for symptomatic vitreomacular adhesion. https://t.co/Pi2hDDN0QE
RT @CochraneEyes: Does ocriplasmin work in the treatment of symptomatic vitreomacular adhesion #sVMA? #Cochane https://t.co/SjvCsCFebR @RCO…
RT @CochraneEyes: Does ocriplasmin work in the treatment of symptomatic vitreomacular adhesion #sVMA? #Cochane https://t.co/SjvCsCFebR @RCO…
RT @CochraneEyes: Does ocriplasmin work in the treatment of symptomatic vitreomacular adhesion #sVMA? #Cochane https://t.co/SjvCsCFebR @RCO…
Ocriplasmin for symptomatic vitreomacular adhesion https://t.co/WHlWfldMxP
Does ocriplasmin work in the treatment of symptomatic vitreomacular adhesion #sVMA? #Cochane https://t.co/SjvCsCFebR @RCOphth https://t.co/4gxfLjNAjD
CochraneLibrary: Ocriplasmin for symptomatic vitreomacular adhesion https://t.co/13WlAEp9Jy https://t.co/wBIJPBpoZN